| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |